Table 1.
Characteristics of Women Diagnosed With Invasive Cervical Cancer in the HIV/AIDS Cancer Match Study from 1996 to 2016
| All Cervical Cancers | Adenocarcinoma | Squamous Cell Carcinoma | ||||
|---|---|---|---|---|---|---|
| Characteristic | WLH | Women Not Living With HIV | WLH | Women Not Living With HIV | WLH | Women Not Living With HIV |
| Number of cases | 609 (1.0%) | 62 006 (99.0%) | 35 (0.3%) | 11 332 (99.7%) | 507 (1.2%) | 42 978 (98.8%) |
| Mean age (standard deviation), years | 43.6 (8.8) | 51.2 (15.6) | 42.9 (7.6) | 50.1 (15.3) | 43.6 (8.7) | 51.1 (15.4) |
| Age categories, years | ||||||
| <35 | 94 (15.4%) | 9408 (15.2%) | 4 (11.4%) | 1785 (15.7%) | 77 (15.2%) | 6478 (15.0%) |
| 35–44 | 273 (44.8%) | 15 473 (25.0%) | 21 (60.0%) | 3238 (28.6%) | 221 (43.6%) | 10 595 (24.7%) |
| 45–54 | 188 (30.9%) | 14 269 (23.0%) | 8 (22.9%) | 2511 (22.2%) | 164 (32.3%) | 10 171 (23.7%) |
| 55+ | 54 (8.9%) | 22 856 (36.9%) | 2 (5.7%) | 3798 (33.5%) | 45 (8.9%) | 15 734 (36.6%) |
| Race | ||||||
| Non-Hispanic White | 55 (9.0%) | 36 236 (58.4%) | 8 (22.9%) | 7907 (69.8%) | 42 (8.3%) | 23 673 (55.1%) |
| Non-Hispanic Black | 398 (65.4%) | 12 495 (20.2%) | 18 (51.4%) | 1315 (11.6%) | 338 (66.7%) | 9626 (22.4%) |
| Hispanic | 156 (25.6%) | 13 275 (21.4%) | 9 (25.7%) | 2110 (18.6%) | 127 (25.0%) | 9679 (22.5%) |
| Time period of cancer diagnosis | ||||||
| 1996–2004 | 181 (29.7%) | 23 660 (38.2%) | 13 (37.1%) | 3715 (32.8%) | 142 (28.0%) | 16 951 (39.4%) |
| 2005–2010 | 272 (44.7%) | 23 810 (38.4%) | 15 (42.9%) | 4494 (39.7%) | 229 (45.2%) | 16 366 (38.1%) |
| 2011–2016 | 156 (25.6%) | 14 536 (23.4%) | 7 (20.0%) | 3123 (27.6%) | 136 (26.8%) | 9661 (22.5%) |
| Tumor stage | ||||||
| Local | 281 (46.1%) | 28 918 (46.7%) | 20 (57.1%) | 6566 (57.9%) | 230 (45.4%) | 19 292 (44.9%) |
| Regional | 185 (30.4%) | 21 079 (34.0%) | 4 (11.4%) | 2642 (23.3%) | 170 (33.5%) | 16 330 (38.0%) |
| Distant | 58 (9.5%) | 6962 (11.2%) | 4 (11.4%) | 1074 (9.5%) | 50 (9.9%) | 4596 (10.7%) |
| Unknown | 85 (14.0%) | 5047 (8.1%) | 7 (20.0%) | 1050 (9.3%) | 57 (11.2%) | 2760 (6.4%) |
| Years from HIV to cancer | N/A | N/A | N/A | |||
| Missing | 77 (12.7%) | 6 (17.1%) | 60 (11.8%) | |||
| <5 | 170 (27.9%) | 13 (37.1%) | 137 (27.0%) | |||
| 5–10 | 198 (32.5%) | 10 (28.6%) | 169 (33.3%) | |||
| >10 | 164 (26.9%) | 6 (17.1%) | 141 (27.8%) | |||
| Mode of exposure | N/A | N/A | N/A | |||
| Injection drug use | 189 (31.0%) | 7 (20.0%) | 158 (31.2%) | |||
| Other /Unknown | 149 (24.5%) | 8 (22.9%) | 221 (43.6%) | |||
| Heterosexual transmission | 271 (44.5%) | 20 (57.1%) | 128 (25.2%) | |||
Abbreviations: HIV, human immunodeficiency virus; N/A, not applicable; WLH, women living with HIV.